Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- DOI
- 10.1056/nejmoa1409077
- Published
- 2014-09-11
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa1409077,
title = {Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure},
author = {John J.V. McMurray and Milton Packer and Akshay S. Desai and Jianjian Gong and Martin P. Lefkowitz and Adel R. Rizkala and Jean L. Rouleau and Victor C. Shi and Scott D. Solomon and Karl Swedberg and Michael R. Zile},
year = {2014},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa1409077},
url = {https://doi.org/10.1056/nejmoa1409077}
}RIS
TY - JOUR TI - Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure AU - John J.V. McMurray AU - Milton Packer AU - Akshay S. Desai AU - Jianjian Gong AU - Martin P. Lefkowitz AU - Adel R. Rizkala AU - Jean L. Rouleau AU - Victor C. Shi AU - Scott D. Solomon AU - Karl Swedberg AU - Michael R. Zile PY - 2014 JO - New England Journal of Medicine DO - 10.1056/nejmoa1409077 UR - https://doi.org/10.1056/nejmoa1409077 ER -
APA
McMurray, J. J., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., & Zile, M. R. (2014). Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1409077
Source records
- crossref · retrieved 2026-11-10T07:57:02.405Z